Physician profile
Rahul Gupta
NPI 1538681457
$23,798.34
in general payments reported to CMS, 2019-2025
21 companies · $570 in 2025
The $570 reported for 2025 was more than what a typical Nuclear Cardiology provider received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $246 · 2021: $163 · 2022: $519 · 2023: $2,776 · 2024: $20K · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $15K · Food and Beverage: $3,517 · Travel and Lodging: $2,495 · Honoraria: $1,200 · Consulting Fee: $438 · Education: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $15,000.00 |
| Food and Beverage | $3,516.88 |
| Travel and Lodging | $2,495.49 |
| Honoraria | $1,200.00 |
| Consulting Fee | $438.00 |
| Education | $220.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,537.07 | 2022-2025 | Corevalve Evolut R, Intellis Adaptivestim, Surgipro Ll |
| Edwards Lifesciences Corporation | $2,138.71 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Chiesi USA, INC. | $1,272.00 | 2023-2024 | Juxtapid, Kengreal |
| Abiomed | $1,203.80 | 2023-2024 | Impella |
| Boston Scientific Corporation | $991.95 | 2022-2024 | Versacross Access Solution |
| Ge Healthcare | $398.00 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $335.70 | 2020-2023 | Lifevest |
| Esperion Therapeutics, INC. | $282.38 | 2020-2022 | |
| Cathworks, INC. | $168.24 | 2023 | Ffrangio |
| Pfizer INC. | $126.05 | 2021-2024 | |
| Abbott Laboratories | $103.60 | 2023-2024 | Diamondback Coronary |
| Penumbra, INC. | $63.06 | 2023 | Indigo System |
| Janssen Pharmaceuticals, INC | $28.66 | 2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.48 | 2022 | |
| Shockwave Medical, INC | $21.77 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $20.54 | 2025 | Flowtriever |
| E.R. Squibb & Sons, L.L.C. | $18.71 | 2022 | |
| Eagle Pharmaceuticals, INC. | $18.32 | 2024 | |
| Novartis Pharmaceuticals Corporation | $17.33 | 2022 | |
| Getinge USA Sales, LLC | $15.09 | 2024 | Cardiosave Hybrid, Type B Plug |
| Astrazeneca Pharmaceuticals Lp | $12.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.